Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Surgery Partners ( (SGRY) ).
Surgery Partners reported fourth-quarter 2025 revenue of $885.0 million, up 2.4% year over year, with same-facility revenue rising 3.5% but overall surgical cases declining 2.1% as Adjusted EBITDA slipped 4.2% to $156.9 million. For full-year 2025, revenue grew 6.2% to $3.3 billion and Adjusted EBITDA increased 3.5% to $526.2 million, even as the company posted a net loss of $77.9 million, and management cited margin pressure and fourth-quarter underperformance amid strong demand and structural tailwinds for ambulatory surgery centers.
The company ended 2025 with $239.9 million in cash, $692.8 million of revolver capacity and net leverage of roughly 4.3x under its credit agreement, while operating cash flow declined to $274.3 million from $300.1 million a year earlier. On February 26, 2026, the board authorized a share repurchase program of up to $200 million, and management issued initial 2026 guidance targeting at least $530 million of Adjusted EBITDA on revenue between $3.35 billion and $3.45 billion, underscoring a focus on higher-acuity procedures, portfolio optimization and long-term shareholder value despite near-term headwinds.
The most recent analyst rating on (SGRY) stock is a Hold with a $15.50 price target. To see the full list of analyst forecasts on Surgery Partners stock, see the SGRY Stock Forecast page.
Spark’s Take on SGRY Stock
According to Spark, TipRanks’ AI Analyst, SGRY is a Neutral.
Surgery Partners’ overall score is driven by strong revenue growth and improving cash flow, but profitability challenges and bearish technical indicators weigh heavily. Revised guidance and valuation concerns further impact the score, despite positive corporate developments.
To see Spark’s full report on SGRY stock, click here.
More about Surgery Partners
Surgery Partners, Inc., headquartered in Brentwood, Tennessee, is a healthcare services company specializing in a differentiated outpatient delivery model for surgical and related ancillary care. Founded in 2004, it operates more than 200 locations across 30 U.S. states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities, focusing on high-quality, cost-effective short-stay surgical services.
Average Trading Volume: 1,646,005
Technical Sentiment Signal: Sell
Current Market Cap: $2B
For an in-depth examination of SGRY stock, go to TipRanks’ Overview page.